Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

Cyproterone acetate is an effective treatment for women with acne, hair loss, and excessive hair growth.

Higher doses of prednisone and triamcinolone acetonide successfully treated 8 out of 10 alopecia totalis patients.

Toothpaste containing α-tocopherol acetate, l-menthol, and stevioside can promote hair growth in mice.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Baricitinib helps with severe hair loss, negative-pressure therapy lowers hernia recurrence, tranexamic acid reduces bleeding, robot-assisted breast surgery may improve outcomes, and acellular dermal matrix could decrease breast reconstruction complications.

Food-derived peptides may help prevent diseases like high blood pressure and high cholesterol, and can support the immune system.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Metabolic signals and cell shape influence how cells develop and change.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

The study suggests that motor neurons created from stem cells of patients with spinal and bulbar muscular atrophy show signs of the disease, including changes in protein levels and cell functions.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Photodynamic Therapy is an effective treatment for mild to severe acne.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

Testosterone's effects on COVID-19 are unclear and need more research.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Alkaline Ceramidase 1 prevents early hair loss in mice by keeping hair follicle stem cells balanced.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

Trichostatin A helps restore hair-growing ability in skin cells used for hair regeneration.